论文信息 - Long‐term follow‐up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer - 字舞流文

Long‐term follow‐up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

M. Piccart | K. Swenerton | I. Vergote | S. Kaye | C. Tropé | J. Cassidy | B. Baron | B. Zee | C. Mangioni | S. Pecorelli | G. Stuart | J. Kaern | J. Paul | W. Mcguire | S. Tumolo | K. Bertelsen | P. Timmers | J. Andersen | J. Roy | R. Blom | M. Bacon | C. Mangioni | R. Atkinson | K. James | E. Simonsen | R. Grimshaw | F. Lhoas | B. Lidvall | A. Birt | I. Vergote | Benny Chung-ying Zee | Benoit Baron | Salvatore Tumolo | S. B. Kaye | S. Pecorelli | M. Piccart | K. Bertelsen | Gavin Stuart | Jim Cassidy | Keith James | Ken D. Swenerton | M. Nardi | Josee Anne Roy | Monica Bacon | James Paul | B. Zee | G. Stuart